Description
Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes, commonly triggered by infections, insufficient insulin therapy, or other stressors. It is characterized by hyperglycemia, ketonemia, metabolic acidosis, and electrolyte imbalances, requiring prompt recognition and aggressive management in the emergency department. The treatment involves fluid resuscitation, insulin therapy to correct hyperglycemia and ketosis, and careful monitoring of electrolytes, particularly potassium, to prevent complications such as arrhythmias.
Summary Listen
- Diabetes Mellitus is a group of metabolic disorders characterized by hyperglycemia. Type 1 diabetes involves autoimmune destruction of pancreatic beta cells, leading to insulin deficiency. In type 2 diabetes, the pancreas secretes insulin, but insulin receptors are incompetent, preventing glucose entry into cells. Long-term diabetes complications include heart attack, stroke, neuropathy, and retinopathy.
- Diabetic Ketoacidosis (DKA) is an acute emergency primarily seen in type 1 diabetes and new-onset type 2 diabetes. Hyperosmolar Hyperglycemic Nonketotic Syndrome (HHNS) is the acute emergency associated with type 2 diabetes. Precipitating factors for DKA include insulin deficiency, infection, infarction, pregnancy, and non-compliance with medication.
- The pathogenesis of DKA involves insulin deficiency, increased counter-regulatory hormones, and decreased glucose utilization. The body breaks down glycogen and lipids for energy, leading to increased free fatty acids and ketone body production. Protein breakdown contributes to gluconeogenesis, further increasing blood glucose.
- Decreased insulin increases counter-regulatory hormones. Decreased glucose utilization increases glucose content. The kidneys pull water from the body, leading to osmotic diuresis, polyuria, dehydration, and hypovolemia.
- Diabetic ketoacidosis is classified based on severity. Diagnosis relies on: random blood glucose levels above 250, bicarbonate levels less than 18, pH levels less than 7.35, positive urine ketones or blood ketones. Severity is categorized based on urine ketones and serum ketones.
- Clinical presentation includes polydipsia, headache, nausea, vomiting, abdominal pain, and Kussmaul breathing. Kussmaul breathing is characterized by deep, labored breathing often accompanied by a fruity acetone breath odor. Tachycardia, hypotension, and dehydration are also common signs.
- Differentiating DKA from HHNS involves assessing glucose levels, ketone presence, and osmolarity. DKA presents with hyperglycemia, ketosis, and metabolic acidosis, while HHNS features very high glucose levels, no ketone bodies, and hyperosmolarity. Venus blood gas analysis and urine analysis are crucial diagnostic tools.
- Management of DKA focuses on IV fluids, insulin, and potassium correction. Potassium levels must be corrected before initiating insulin therapy to prevent hypokalemia. Complications of DKA management include cerebral edema, hypokalemia, and hypoglycemia.
- Bicarbonate administration is generally avoided unless severe metabolic acidosis is present, due to potential complications. Other complications associated with DKA include thromboembolic events, volume overload, electrolyte imbalances, and infections.
- DKA management is stopped when the patient can tolerate oral intake, vomiting stops, urine and blood ketone levels return to zero, pH normalizes, and serum bicarbonate levels improve. This signals resolution of DKA, and the patient can transition to subcutaneous insulin or oral medication.
Sample Certificate
About the Speakers
Comments
Comments
You must be logged in to leave a comment.